| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 168.97B | 170.34B | 138.59B | 86.38B | 78.37B | 69.72B |
| Gross Profit | 41.59B | 40.79B | 29.98B | 17.24B | 17.45B | 14.55B |
| EBITDA | 21.66B | 23.07B | 36.69B | 9.48B | 10.16B | 7.65B |
| Net Income | 9.54B | 8.76B | 26.32B | 4.32B | 4.33B | 1.88B |
Balance Sheet | ||||||
| Total Assets | 211.46B | 221.59B | 223.40B | 123.73B | 115.71B | 110.54B |
| Cash, Cash Equivalents and Short-Term Investments | 26.71B | 28.02B | 24.44B | 23.82B | 16.21B | 12.61B |
| Total Debt | 18.68B | 20.32B | 20.69B | 10.00B | 10.00B | 10.00B |
| Total Liabilities | 60.86B | 66.92B | 73.98B | 28.75B | 28.63B | 30.40B |
| Stockholders Equity | 142.29B | 145.25B | 140.55B | 88.57B | 81.22B | 74.92B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 10.22B | 12.40B | 8.30B | 4.01B | 4.13B |
| Operating Cash Flow | 0.00 | 17.48B | 18.50B | 10.96B | 6.42B | 7.39B |
| Investing Cash Flow | 0.00 | -7.08B | -13.55B | -3.85B | -3.82B | -2.91B |
| Financing Cash Flow | 0.00 | -8.40B | -8.62B | -1.45B | -1.52B | -1.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥103.66B | 6.62 | ― | 3.82% | ― | ― | |
77 Outperform | ¥123.53B | 7.27 | ― | 3.30% | 0.29% | 9.87% | |
74 Outperform | ¥162.46B | 13.70 | ― | 4.47% | 2.01% | 25.09% | |
70 Outperform | ¥56.03B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
69 Neutral | ¥212.91B | 10.65 | 7.50% | 5.39% | -2.26% | ― | |
68 Neutral | ¥193.40B | -8.32 | ― | 1.93% | -3.23% | 24.93% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |